Systems-Based Epilepsy Assessment Across Comorbidity Indices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical practices focus on individual diseases or disorders, neglecting their 'spill-over' effects on overall patient health and well-being, leading to imprecise and distorted findings due to the complex, non-linear interactions within the human body's network systems.
Innovation Solution
A systems approach that assesses the state of a disease and its co-morbidities using autonomic, neurologic, psychiatric, and endocrine indices, comparing them to reference values to determine disease progression, regression, or stability, and providing outputs on patient health and well-being.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional compartmentalized medical practice focuses on individual diseases, then diagnostic and therapeutic efforts can be concentrated on specific disorders, but the spill-over effects of disease and treatment on overall patient health are ignored leading to imprecise findings
Solution Approach 1:
The patent combines multiple disease assessments into a unified systems-based evaluation framework that simultaneously evaluates primary diseases and co-morbidities. The system integrates assessments across different body systems (neurologic, psychiatric, endocrine, autonomic) to provide a comprehensive view of patient health that captures spill-over effects between diseases, thereby improving measurement precision without requiring separate compartmentalized assessments for each condition.
Solution Approach 2:
The assessment system is designed to be universally applicable across multiple disease types and body systems. A single integrated framework can evaluate various primary diseases and their associated co-morbidities simultaneously, making the system multi-functional rather than disease-specific. This universal approach allows the same system to assess neurologic, psychiatric, endocrine, and autonomic conditions together, improving overall assessment precision.
2Loss of information
If traditional practice compartmentalizes diseases into constituent parts, then study and treatment of specific disorders is facilitated, but substantial loss of information occurs because the assembly of systems is greater than the sum of its parts
Solution Approach 1:
The system merges evaluations of multiple body systems and disease states into a unified assessment framework. By combining neurologic, psychiatric, endocrine, and autonomic assessments into a single integrated system, the patent captures the emergent properties of disease assemblies that would be lost in compartmentalized approaches, thereby reducing information loss about overall patient health.
Solution Approach 2:
The systems-based assessment framework incorporates feedback mechanisms that evaluate how changes in one body system affect other systems. This feedback approach captures the dynamic interactions between diseases and treatments, preserving information about how disease assemblies function as integrated wholes rather than isolated parts, thus reducing information loss.
Data Source
AI summary
Methods, systems, and apparatus for assessing a state of an epilepsy disease or a comorbidity thereof are provided. The methods comprise receiving at least one autonomic index, neurologic index, stress marker index, psychiatric index, endocrine index, adverse effect of therapy index, physical fitness index, or quality of life index of a patient; comparing the at least one index to at least one reference value; and assessing a state of an epilepsy disease or a body system of the patient based on the comparison. A computer readable program storage device encoded with instructions that, when executed by a computer, perform the method described above is also provided. A medical device system capable of implementing the method described above is also provided.